Stay updated on Psilocybin for Cocaine Use Disorder Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for Cocaine Use Disorder Clinical Trial page.

Latest updates to the Psilocybin for Cocaine Use Disorder Clinical Trial page
- ChecktodayChange DetectedUpdated the page revision to v3.0.2 from v3.0.1 and removed the 'Back to Top' element.SummaryDifference0.1%
- Check7 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check15 days agoChange DetectedThe web page has undergone significant updates, including the addition of a new facility name and location, as well as detailed drug information for Diphenhydramine. However, it has removed extensive drug-related content, including information on Promethazine and various drug classifications.SummaryDifference4%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check36 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.11, replacing the previous version v2.16.10. The phrasing for the last update has also changed from 'Estimated' to a definitive statement.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated to reflect a revised study protocol for psilocybin-facilitated treatment for cocaine use, including changes to participant preparation sessions, drug administration procedures, and follow-up assessments. Notably, the names of the therapists involved have been updated, and the timeline for assessments has been clarified.SummaryDifference15%
Stay in the know with updates to Psilocybin for Cocaine Use Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for Cocaine Use Disorder Clinical Trial page.